FFA
NGNE icon

Farther Finance Advisors’s Neurogene NGNE Stock Holding History

Farther Finance Advisors’s Portfolio NGNE Stock Details NGNE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.65K Buy
176
+6
+4% +$165 ﹤0.01% 4740
2026
Q1 		$3.68K Buy
+170
New +$3.29K ﹤0.01% 4642
2025
Q4 		– Sell
-597
Closed -$10.3K – 5548
2025
Q3 		$10.3K Buy
+597
New +$12K ﹤0.01% 3431
2025
Q2 		– Sell
-50
Closed -$483 – 4612
2025
Q1 		$483 Hold
50
– – ﹤0.01% 3782
2024
Q4 		$1.14K Hold
50
– – ﹤0.01% 3204
2024
Q3 		$2.1K Hold
50
– – ﹤0.01% 2978
2024
Q2 		$2.03K Hold
50
– – ﹤0.01% 2788
2024
Q1 		$2.34K Hold
50
– – ﹤0.01% 2423
2023
Q4 		$969 Hold
50
– – ﹤0.01% 2745
2023
Q3 		$790 Hold
50
– – ﹤0.01% 2144
2023
Q2 		$830 Buy
+50
New +$820 ﹤0.01% 2027

Other funds holding NGNE

PFSRSONJ
Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $4.4B AUM 74.25% 1-Year Est. Return
FFO
Fortitude Family Office Scottsdale, Arizona $516M AUM 28.38% 1-Year Est. Return
HFS
Hughes Financial Services Herndon, Virginia $755M AUM 20.43% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Farther Finance Advisors's NGNE Position: Q2 2026 in Review

Farther Finance Advisors increased its Neurogene (NGNE) stake by 3.5% in Q2 2026, buying an estimated $165 and bringing the position to 176 shares worth $5.65K. The position accounts for ﹤0.01% of the portfolio, ranked #4740.

Farther Finance Advisors first reported a position in NGNE in Q2 2023 and has held it in 11 quarters since. The position peaked at $10.3K in Q3 2025. 8 funds tracked by Wall St. Rank hold NGNE as of Q2 2026.

  • Farther Finance Advisors held 176 shares of Neurogene worth $5.65K as of Q2 2026.
  • Farther Finance Advisors bought 6 Neurogene shares in Q2 2026, an estimated $165.
  • Neurogene made up ﹤0.01% of Farther Finance Advisors's portfolio in Q2 2026, its #4740 holding.
  • Farther Finance Advisors first reported a position in Neurogene in Q2 2023 and has held it in 11 quarters since.
  • Farther Finance Advisors's Neurogene position peaked at $10.3K in Q3 2025.
  • 8 funds tracked by Wall St. Rank held Neurogene as of Q2 2026.

Based on Farther Finance Advisors's 13F filing for Q2 2026, filed 17 Jul 2026.